CVS Health Corp. is well-positioned in the healthcare sector, showing stable growth supported by its diversified segments, including Health Care Benefits and Pharmacy & Consumer Wellness. The company's overall robust performance makes it a compelling stock for investors interested in the healthcare industry.
The fundamental scores indicate a balanced outlook with potential for growth in certain areas.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
The historical data illustrates a steady track record with room for improvement in some metrics.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-23 | 3 | 5 | 3 | 3 | 1 | 2 | 4 |
Analyst consensus suggests a "Buy" rating, with expectations of a price increase.
| High | Low | Median | Consensus |
|---|---|---|---|
| $123 | $90 | $108 | $106.57 |
The sentiment among analysts is predominantly positive, with a strong inclination towards buying.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 33 | |
| Hold | 6 | |
| Sell | 0 | |
| Strong Sell | 0 |
CVS Health Corp. offers investors a stable investment opportunity, supported by its strong position in the healthcare sector. The fundamental analysis suggests the company is on a stable trajectory with potential for growth, especially in its core segments. Analyst sentiment is overwhelmingly positive, indicating confidence in the company's future performance. Despite a moderate debt-to-equity score, the overall financial health is considered favorable. Investors should weigh the potential for growth against sector-specific risks.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.